Request Deal Involvement
Arya Sciences Acquisition II competed the merger with Cerevel Therapeutics in a $1.3bn deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Ropes & Gray
financial advisors
Jefferies & Company
legal advisors
Kirkland & Ellis
financial advisors
Goldman Sachs
financial advisors
Evercore
legal advisors
Goodwin Procter
commercial advisors
Sodali & Co
financial advisors
Stifel
financial advisors
Morgan Stanley
pr advisors
W2O Group
or
Principals
bidder
ECOR1 CAPITAL
bidder
THE INVUS GROUP LLC
bidder
SURVEYOR CAPITAL
bidder
PFIZER INC
bidder
BOXER CAPITAL
bidder
T. ROWE PRICE GROUP INC
bidder
ADAGE CAPITAL MANAGEMENT
bidder
FEDERATED INVESTORS INC
bidder
PERCEPTIVE ADVISORS LLC
bidder
ALLY BRIDGE GROUP
bidder
FIDELITY MANAGEMENT & RESEARCH COMPANY
bidder
NOVALIS LIFESCIENCES
bidder
RA CAPITAL MANAGEMENT
bidder
ROCK SPRINGS CAPITAL
bidder
SPHERA HEALTHCARE
bidder
BAIN CAPITAL LP
bidder
ARYA SCIENCES ACQUISITION CORP II
target
CEREVEL THERAPEUTICS
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite